Register for updates

 
 

Medicine & Health
RSS Feed
Cyborg Cardiac Patch May Treat the Diseased Heart
Monday, March 14, 2016 12:01:00 PM

TAU researchers combine electronics with living tissues to create a self-regulating cardiac patch

More than 25% of the people on the national US waiting list for a heart will die before receiving one. Despite this discouraging figure, heart transplants are still on the rise. There just hasn't been an alternative. Until now.

The "cyborg heart patch," a new engineering innovation from Tel Aviv University, may single-handedly change the field of cardiac research. The bionic heart patch combines organic and engineered parts. In fact, its capabilities surpass those of human tissue alone. The patch contracts and expands like human heart tissue but regulates itself like a machine.

The invention is the brainchild of Prof. Tal Dvir and PhD student Ron Feiner of TAU's Department of Biotechnology, Department of Materials Science and Engineering, and Center for Nanoscience and Nanotechnology. Their study was published today in the journal Nature Materials.

Science fiction becomes science fact

"With this heart patch, we have integrated electronics and living tissue," Dr. Dvir said. "It's very science fiction, but it's already here, and we expect it to move cardiac research forward in a big way.

"Until now, we could only engineer organic cardiac tissue, with mixed results. Now we have produced viable bionic tissue, which ensures that the heart tissue will function properly."

Prof. Dvir's Tissue Engineering and Regenerative Medicine Lab at TAU has been at the forefront of cardiac research for the last five years, harnessing sophisticated nanotechnological tools to develop functional substitutes for tissue permanently damaged by heart attacks and cardiac disease. The new cyborg cardiac patch not only replaces organic tissue but also ensures its sound functioning through remote monitoring.

"We first ensured that the cells would contract in the patch, which explains the need for organic material," said Dr. Dvir. "But, just as importantly, we needed to verify what was happening in the patch and regulate its function. We also wanted to be able to release drugs from the patch directly onto the heart to improve its integration with the host body."

For the new bionic patch, Dr. Dvir and his team engineered thick bionic tissue suitable for transplantation. The engineered tissue features electronics that sense tissue function and accordingly provide electrical stimulation. In addition, electroactive polymers are integrated with the electronics. Upon activation, these polymers are able to release medication, such as growth factors or small molecules on demand.

Cardiac therapy in real time

"Imagine that a patient is just sitting at home, not feeling well," Dr. Dvir said. "His physician will be able to log onto his computer and this patient's file — in real time. He can view data sent remotely from sensors embedded in the engineered tissue and assess exactly how his patient is doing. He can intervene to properly pace the heart and activate drugs to regenerate tissue from afar.

"The longer-term goal is for the cardiac patch to be able to regulate its own welfare. In other words, if it senses inflammation, it will release an anti-inflammatory drug. If it senses a lack of oxygen, it will release molecules that recruit blood-vessel-forming cells to the heart."

Dr. Dvir is currently examining how his proof of concept could apply to the brain and spinal cord to treat neurological conditions.

"This is a breakthrough, to be sure," Dr. Dvir said. "But I would not suggest binging on cheeseburgers or quitting sports just yet. The practical realization of the technology may take some time. Meanwhile, a healthy lifestyle is still the best way to keep your heart healthy."

Image caption: A remotely regulated living bionic heart. The engineered tissue is comprised of living cardiac cells, polymers, and a complex nanoelectronic system. This integrated electronic system provides enhanced capabilities, such as online sensing of heart contraction, and pacing when needed. In addition, the electronics can control the release of growth factors and drugs, for stem cell recruitment and to decrease inflammation after transplantation. Credit: Tel Aviv University.




Latest News

Joanna Naftali Named Associate Vice President, Midwest of AFTAU

Accomplished fundraiser has deep roots in educational, philanthropic, and arts sectors.

Blocking Inflammatory Pathway Key to Preventing Brain Metastasis from Melanoma

Tumor cells "hijack" their way to the brain through an inflammatory factor secreted by brain cells, say TAU researchers.

TAU and Technion Researchers Wrest Control of One of World's Most Secure PLCs

Rogue engineering station instigated "hostile intervention" of Siemens programmable logic controller that runs industrial processes.

Novel Immunotherapy May Prevent Brain Metastases

Injection of synthetic DNA material found to activate brain's immune cells and kill invading tumor cells, TAU researchers say.

TAU Scientists Develop Novel Nano-Vaccine for Melanoma

Injection of nanoparticle has proven effective in mouse models, researchers say.

Genetic Screen Identifies Genes That Protect Cells from Zika Virus

Genes found to safeguard against infection as well as resuscitate infected cells, TAU researchers say.

Jennifer Gross Named Chief Executive Officer of AFTAU

Accomplished executive brings extensive experience from Jewish philanthropy and the financial services industry.

Fat Cells Play Key Role in Dangerous Transformation of Melanoma

Fat cells allow melanoma cells to penetrate the dermis, causing fatal metastases in vital organs, TAU researchers say.

New Antibacterial Fillings from TAU May Combat Recurring Tooth Decay

Novel material may prevent one of the costliest and most prevalent bacterial diseases in the world.

First Proof-of-Concept Demonstrates Genetic Sex Selection in Mammals

Crossed transgenic mouse lines struck males without affecting females, TAU researchers say.

contentSecondary
c

© 2019 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University